Intec Pharma Ltd. announced that Zeev Weiss, Chief Executive Officer and a Director of the company, is resigning from both positions effective immediately to pursue other professional opportunities. Mr. Weiss will serve as a clinical and business development consultant to Intec Pharma. The company's Board of Directors have appointed Giora Carni, a Director since 2006 and Chief Executive Officer of Intec Pharma from 2006 to 2014, as Interim Chief Executive Officer while a search for a new Chief Executive Officer has been initiated.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.36 USD | -4.84% | -1.67% | +34.09% |
05-08 | Indaptus Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-14 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.09% | 20.15M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.72% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- INDP Stock
- News Indaptus Therapeutics, Inc.
- Intec Pharma Ltd. Announces Management Changes